» Articles » PMID: 36716094

Dysbiosis in Gastrointestinal Pathophysiology: Role of the Gut Microbiome in Gulf War Illness

Overview
Journal J Cell Mol Med
Date 2023 Jan 30
PMID 36716094
Authors
Affiliations
Soon will be listed here.
Abstract

Gulf War Illness (GWI) has been reported in 25%-35% of veterans returned from the Gulf war. Symptoms of GWI are varied and include both neurological and gastrointestinal symptoms as well as chronic fatigue. Development of GWI has been associated with chemical exposure particularly with exposure to pyridostigmine bromide (PB) and permethrin. Recent studies have found that the pathology of GWI is connected to changes in the gut microbiota, that is the gut dysbiosis. In studies using animal models, the exposure to PB and permethrin resulted in similar changes in the gut microbiome as these found in GW veterans with GWI. Studies using animal models have also shown that phytochemicals like curcumin are beneficial in reducing the symptoms and that the extracellular vesicles (EV) released from gut bacteria and from the intestinal epithelium can both promote diseases and suppress diseases through the intercellular communication mechanisms. The intestinal epithelium cells produce EVs and these EVs of intestinal epithelium origin are found to suppress inflammatory bowel disease severity, suggesting the benefits of utilizing EV in treatments. On the contrary, EV from the plasma of septic mice enhanced the level of proinflammatory cytokines in vitro and neutrophils and macrophages in vivo, suggesting differences in the EV depending on the types of cells they were originated and/or influences of environmental changes. These studies suggest that targeting the EV that specifically have positive influences may become a new therapeutic strategy in the treatment of veterans with GWI.

Citing Articles

Crisis in the gut: navigating gastrointestinal challenges in Gulf War Illness with bioengineering.

Collier C, Salikhova A, Sabir S, Foncerrada S, Raghavan S Mil Med Res. 2024; 11(1):45.

PMID: 38978144 PMC: 11229309. DOI: 10.1186/s40779-024-00547-2.


A Double-Humanized Mouse Model for Studying Host Gut Microbiome-Immune Interactions in Gulf War Illness.

Bose D, Saha P, Roy S, Trivedi A, More M, Klimas N Int J Mol Sci. 2024; 25(11).

PMID: 38892281 PMC: 11172868. DOI: 10.3390/ijms25116093.


What is the association between the microbiome and cognition? An umbrella review protocol.

Goldenberg J, Wright T, Batson R, Wexler R, McGovern K, Venugopal N BMJ Open. 2024; 14(6):e077873.

PMID: 38890133 PMC: 11191802. DOI: 10.1136/bmjopen-2023-077873.


Disentangling the effects of PTSD from Gulf War Illness in male veterans via a systems-wide analysis of immune cell, cytokine, and symptom measures.

Sultana E, Shastry N, Kasarla R, Hardy J, Collado F, Aenlle K Mil Med Res. 2024; 11(1):2.

PMID: 38167090 PMC: 10759613. DOI: 10.1186/s40779-023-00505-4.


Dysbiosis in gastrointestinal pathophysiology: Role of the gut microbiome in Gulf War Illness.

Slevin E, Koyama S, Harrison K, Wan Y, Klaunig J, Wu C J Cell Mol Med. 2023; 27(7):891-905.

PMID: 36716094 PMC: 10064030. DOI: 10.1111/jcmm.17631.

References
1.
Zeng M, Inohara N, Nunez G . Mechanisms of inflammation-driven bacterial dysbiosis in the gut. Mucosal Immunol. 2016; 10(1):18-26. PMC: 5788567. DOI: 10.1038/mi.2016.75. View

2.
Schirmer M, Garner A, Vlamakis H, Xavier R . Microbial genes and pathways in inflammatory bowel disease. Nat Rev Microbiol. 2019; 17(8):497-511. PMC: 6759048. DOI: 10.1038/s41579-019-0213-6. View

3.
Janulewicz P, Krengel M, Quinn E, Heeren T, Toomey R, Killiany R . The Multiple Hit Hypothesis for Gulf War Illness: Self-Reported Chemical/Biological Weapons Exposure and Mild Traumatic Brain Injury. Brain Sci. 2018; 8(11). PMC: 6266762. DOI: 10.3390/brainsci8110198. View

4.
Fukuda K, Nisenbaum R, Stewart G, Thompson W, Robin L, Washko R . Chronic multisymptom illness affecting Air Force veterans of the Gulf War. JAMA. 1998; 280(11):981-8. DOI: 10.1001/jama.280.11.981. View

5.
Koyama S, Kondo K, Ueha R, Kashiwadani H, Heinbockel T . Possible Use of Phytochemicals for Recovery from COVID-19-Induced Anosmia and Ageusia. Int J Mol Sci. 2021; 22(16). PMC: 8396277. DOI: 10.3390/ijms22168912. View